Needham & Company LLC Has Lowered Expectations for Doximity (NYSE:DOCS) Stock Price

Doximity (NYSE:DOCS) had its target price decreased by analysts at Needham & Company LLC from $55.00 to $27.00 in a research note issued to investors on Thursday, Marketbeat.com reports. The brokerage currently has a “buy” rating on the stock. Needham & Company LLC’s price objective suggests a potential upside of 42.67% from the stock’s previous close.

Other equities research analysts have also issued research reports about the company. Royal Bank Of Canada restated an “outperform” rating and issued a $44.00 price objective on shares of Doximity in a research report on Monday, March 9th. JPMorgan Chase & Co. lowered their price objective on Doximity from $40.00 to $33.00 and set a “neutral” rating on the stock in a research report on Friday, February 20th. Canaccord Genuity Group set a $34.00 price objective on Doximity and gave the stock a “buy” rating in a research report on Monday, February 9th. Bank of America lowered their price objective on Doximity from $56.00 to $47.00 and set a “buy” rating on the stock in a research report on Thursday, April 16th. Finally, Robert W. Baird restated a “neutral” rating and issued a $18.00 price objective (down from $40.00) on shares of Doximity in a research report on Thursday. Two equities research analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating and fourteen have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $30.62.

Doximity Trading Up 5.1%

Shares of NYSE DOCS opened at $18.93 on Thursday. The firm has a 50 day moving average price of $23.94. The stock has a market capitalization of $3.50 billion, a price-to-earnings ratio of 19.12, a P/E/G ratio of 1.28 and a beta of 1.36. Doximity has a 52 week low of $17.15 and a 52 week high of $76.51.

Doximity declared that its Board of Directors has initiated a share repurchase plan on Thursday, February 5th that allows the company to buyback $500.00 million in outstanding shares. This buyback authorization allows the company to buy up to 8% of its stock through open market purchases. Stock buyback plans are often a sign that the company’s board of directors believes its stock is undervalued.

Insider Buying and Selling

In other news, insider Siddharth Sitaram sold 2,427 shares of the stock in a transaction that occurred on Friday, April 10th. The stock was sold at an average price of $21.09, for a total transaction of $51,185.43. Following the transaction, the insider owned 86,705 shares in the company, valued at $1,828,608.45. This trade represents a 2.72% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Kira Scherer Wampler sold 9,000 shares of the stock in a transaction that occurred on Thursday, May 7th. The shares were sold at an average price of $26.06, for a total value of $234,540.00. Following the transaction, the director owned 19,839 shares in the company, valued at $517,004.34. This trade represents a 31.21% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 18,055 shares of company stock worth $456,061 in the last quarter. Insiders own 31.30% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in DOCS. Root Financial Partners LLC acquired a new position in Doximity in the 3rd quarter valued at $30,000. Whittier Trust Co. of Nevada Inc. raised its stake in Doximity by 59.5% in the 3rd quarter. Whittier Trust Co. of Nevada Inc. now owns 480 shares of the company’s stock valued at $35,000 after purchasing an additional 179 shares during the last quarter. Northwestern Mutual Wealth Management Co. raised its stake in Doximity by 99.5% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 796 shares of the company’s stock valued at $35,000 after purchasing an additional 397 shares during the last quarter. Toth Financial Advisory Corp raised its stake in Doximity by 100.0% in the 4th quarter. Toth Financial Advisory Corp now owns 1,000 shares of the company’s stock valued at $44,000 after purchasing an additional 500 shares during the last quarter. Finally, Atlantic Union Bankshares Corp raised its stake in Doximity by 136.9% in the 3rd quarter. Atlantic Union Bankshares Corp now owns 616 shares of the company’s stock valued at $45,000 after purchasing an additional 356 shares during the last quarter. Hedge funds and other institutional investors own 87.19% of the company’s stock.

Doximity News Summary

Here are the key news stories impacting Doximity this week:

• Positive Sentiment: Doximity said revenue still grew year over year, and its earnings call highlighted strong engagement from AI tool adoption, suggesting the platform is gaining traction with physicians. Doximity Stock Falls on Q4 Earnings Miss, Revenues Beat, Margins Down
• Positive Sentiment: Doximity announced a partnership with Aledade to bring clinical AI tools into value-based care workflows, which could support longer-term adoption and monetization. DOCS Teams Up With Aledade to Bring Clinical AI to Value-Based Care
• Neutral Sentiment: Several articles noted the stock has become technically oversold after a sharp selloff, which could set up a bounce if sentiment improves. Down 25.7% in 4 Weeks, Here’s Why Doximity (DOCS) Looks Ripe for a Turnaround
• Negative Sentiment: Doximity missed quarterly earnings estimates and issued fiscal 2027 revenue guidance below Wall Street expectations, raising concerns that growth is slowing. Doximity, Inc. (DOCS) Q4 2026 Earnings Call Transcript
• Negative Sentiment: Analysts turned more cautious, with multiple firms cutting price targets or downgrading the stock, including Baird, Wells Fargo, BTIG, JPMorgan, Mizuho, BMO, Needham and Truist. DOCS vs. HIMS: Which Stock Is the Better Value Option?
• Negative Sentiment: Investor caution also increased after insider selling was disclosed, even though it was tied to a pre-arranged 10b5-1 plan and tax withholding. Doximity (NYSE:DOCS) Insider Siddharth Sitaram Sells 2,309 Shares

Doximity Company Profile

Doximity, trading as DOCS, operates a digital professional network and communications platform designed primarily for clinicians. Headquartered in San Francisco, the company connects physicians, nurse practitioners, physician assistants and other healthcare professionals, providing tools that streamline clinical communication, telehealth delivery and access to specialty-specific medical information. Its platform is positioned as a professional hub where clinicians manage their workflows, stay current with medical news and collaborate securely with peers.

The company’s offerings include secure messaging and video telehealth capabilities that enable clinicians to consult with patients and colleagues while protecting patient information.